Yüklüyor......
AKT/GSK3β Signaling in Glioblastoma
Glioblastoma (GBM) is the most aggressive of primary brain tumors. Despite the progress in understanding the biology of the pathogenesis of glioma made during the past decade, the clinical outcome of patients with GBM remains still poor. Deregulation of many signaling pathways involved in growth, su...
Kaydedildi:
| Yayımlandı: | Neurochem Res |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer US
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5357492/ https://ncbi.nlm.nih.gov/pubmed/27568206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11064-016-2044-4 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|